Tripartite Motif Containing 52 Positively Regulates NF-κB Signaling by Promoting IκBα Ubiquitination in

Pei Zhang1, Yimin Wu1, Ruifeng Li1

  • 1Department of Orthopedics, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China (mainland).

Insights

Tripartite motif containing 52 (TRIM52) activates the NF-kappaB pathway by promoting IkappaBalpha ubiquitination, regulating microglial cell activation and inflammation after spinal cord injury.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglial cell activation is a primary response to spinal cord injury (SCI).
  • Understanding the molecular mechanisms governing microglial activation is crucial for developing therapeutic strategies.
  • Tripartite motif containing 52 (TRIM52) has emerged as a potential regulator in cellular processes.

Purpose of the Study:

  • To investigate the role of TRIM52 in microglial cell activation.
  • To elucidate the underlying mechanism of TRIM52 in regulating inflammatory responses.
  • To determine the effect of TRIM52 on the NF-kappaB signaling pathway.

Main Methods:

  • Primary rat microglial cells were isolated and activated using lipopolysaccharide (LPS).
  • TRIM52 expression was manipulated using lentivirus-mediated overexpression and knockdown.
  • Cytokine levels (IL-1ß, TNF-α), NF-kappaB signaling, and protein interactions were analyzed using ELISA, Western blot, and Co-IP.

Main Results:

  • LPS stimulation increased microglial activation, cytokine production, TRIM52 expression, and NF-kappaB nuclear translocation.
  • TRIM52 knockdown reduced these inflammatory markers, while TRIM52 overexpression enhanced them.
  • TRIM52 was found to interact with IkappaBalpha, promoting its ubiquitination and degradation.

Conclusions:

  • TRIM52 plays a significant role in regulating LPS-induced microglial activation and inflammation.
  • TRIM52 activates the NF-kappaB signaling pathway by promoting IkappaBalpha ubiquitination.
  • Targeting TRIM52 may offer a therapeutic approach for managing neuroinflammation in SCI.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.8K